| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Loewald
CEO | Chief Executive Officer | 63 | 06/09/2020 |
Matthew Bio
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2022 |
Brian Swierenga
COO | Chief Operating Officer | - | 30/09/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Wayne Hewett
CHM | Chairman | 61 | 30/11/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +0.08% | - | - | 2.02B | ||
| -1.64% | +1.16% | +54.09% | +109.07% | 1,026B | ||
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | ||
| -0.05% | +0.98% | +19.08% | +73.55% | 468B | ||
| -0.25% | +0.19% | +36.95% | +45.63% | 352B | ||
| +0.98% | +2.91% | +20.59% | +27.91% | 271B | ||
| -1.91% | +2.42% | +10.41% | +12.53% | 256B | ||
| -1.01% | +7.90% | +41.59% | +51.70% | 220B | ||
| -0.85% | +2.50% | +32.32% | +101.80% | 188B | ||
| -2.53% | -7.47% | -32.63% | -60.67% | 170B | ||
| Average | -0.21% | +1.26% | +26.09% | +47.69% | 399.9B | |
| Weighted average by Cap. | +0.44% | +1.26% | +35.94% | +65.92% |
Employees
-
Sector
Pharmaceuticals
















